WellDyne Leaders Share Digital Insights

Digital therapeutics are everywhere. In fact, there’s a chance you have more than one on your smartphone right now or are wearing one on your wrist. These apps are changing the landscape of healthcare through better monitoring, data collection and patient engagement. At the same time, they present unique challenges to payers – challenges that PBMs can help solve.

WellDyne thought leaders are sharing their expertise at the PBMI Annual National Conference. Nick Page, Chief Clinical & Strategy Officer and Patty Taddei-Allen, VP, Clinical Programs & Services will help participants analyze opportunities and challenges in determining how digital therapeutics and health technology tools are included or excluded from formularies.

Digital Formularies: Harnessing Digital Innovation
Presented by Nick Page and Patty Taddei-Allen
PBMI Annual National Conference
Tuesday, September 13, 4-5 pm

“Harnessing digital innovation can be more difficult than it sounds in the complex pharmacy industry,” Patty explains. “PBMs are well positioned to navigate this new, digital world and help steer informed decisions regarding which tools to provide to members – and which to avoid.”

Digital health formularies help promote safety, efficacy and usability. These formularies typically include applications that are technology and/or software enabled, and are evaluated on their therapeutic value, outcomes, cost effectiveness, usability and security. The PBMI session will include discussion around the framework for formulary evaluation and best practices, leading participants through an overview of PBM expertise that can be applied in this high-impact area.

Additional WellDyne Sessions:

Digital Therapeutics – Platform as a Service
Panelist: Patty Taddei-Allen, VP, Clinical Programs & Services
Monday, September 12, 2:10-3:10 pm

Obesity: The Why and How of Treatment and Coverage
Co-presenter with Novo Nordisk: David Skomo, Chief Operating Officer
Wednesday, September 14, 9:00-10:00 am